X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

VLON

Closed

Vallon Pharmaceuticals Inc

8.585
-3.415 (-28.46%)
Last Update: 24 Apr 2023 16:30:00
Yesterday: 12.
Day's Range: 7.61 - 13.33
Send
When Written:
 
0.4119
Vallon Pharmaceuticals Inc. is a biopharmaceutical company that is focused on developing and commercializing novel drugs for central nervous system (CNS) disorders. The company's lead product candidate is called ADAIR, which is a novel formulation of dextroamphetamine that is being developed for the treatment of attention deficit hyperactivity disorder (ADHD) in adults.

Vallon Pharmaceuticals was founded in 2018 and is headquartered in Philadelphia, Pennsylvania. The company is led by a team of experienced executives and scientists with a track record of developing and commercializing CNS drugs.

In addition to ADAIR, Vallon Pharmaceuticals is also developing other CNS drug candidates, including a novel formulation of methylphenidate for the treatment of ADHD and a non-opioid painkiller for the treatment of acute pain.

Vallon Pharmaceuticals is a publicly traded company and is listed on the NASDAQ stock exchange under the ticker symbol "VLON".

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:52.15.226.148
X